What is AtriCure's stock-based comp?

AtriCure (ATRC) reported stock-based comp of $11.27M in Q1 2026.

How has AtriCure's stock-based comp changed year-over-year?

AtriCure's stock-based comp increased by 17.1% year-over-year, from $9.63M to $11.27M.

What is the long-term trend for AtriCure's stock-based comp?

Over 4 years (2021 to 2025), AtriCure's stock-based comp has grown at a 12.3% compound annual growth rate (CAGR), from $28.08M to $44.69M.

What does stock-based comp mean?

Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

AtriCure ATRC Stock-Based Comp

Stock-Based Comp at other companies

AbbottABT

$317M+9.7%

Johnson & JohnsonJNJ

$300M+4.2%

Boston ScientificBSX

$83M+12.2%

MedtronicMDT

$95M+6.7%

Pulse Biosciences, Inc.PLSE

$1.91M-66.3%

ITG

Integer HoldingsITGR

$6.66M-3.2%

Other financials

Income statement

See full

Revenue$141.2M+14.3%

Gross profit$109.3M+18.0%

Operating income$526.0K+109%

Net income$108.0K+102%

EPS (diluted)$0.00+100%

Balance sheet

See full

Cash & equivalents$146.2M+46.3%

Total debt$76.2M-3.1%

Total equity$491.7M+8.2%

Total assets$644.0M+8.8%

Cash flow

See full

Operating cash flow-$4.0M+63.8%

CapEx$3.9M+76.6%

Free cash flow-$7.8M+40.6%

Valuation

See full

Market cap$1.43B-9.9%

Enterprise value$1.36B-13.1%

P/S2.6×-0.7×

Profitability

See full

Gross margin75.6%+0.8pp

Operating margin-5.1%-1.3pp

Net margin-5.6%-1.5pp

FCF margin9.7%—

Returns & leverage

See full

Return on equity-6.1%-1.3pp

Debt / equity0.2×0.0×

Current ratio4.3×+0.2×

Where this comes from

Reported directly by AtriCure in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: AtriCure’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about AtriCure's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AtriCure's stock-based comp?: AtriCure (ATRC) reported stock-based comp of $11.27M in Q1 2026.
How has AtriCure's stock-based comp changed year-over-year?: AtriCure's stock-based comp increased by 17.1% year-over-year, from $9.63M to $11.27M.
What is the long-term trend for AtriCure's stock-based comp?: Over 4 years (2021 to 2025), AtriCure's stock-based comp has grown at a 12.3% compound annual growth rate (CAGR), from $28.08M to $44.69M.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.